Panchsheel Organics [PANCHSHEEL] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Panchsheel Organics Ltd. wins in 8 metrics, Sun Pharmaceutical Industries Ltd. wins in 11 metrics, with 0 ties. Sun Pharmaceutical Industries Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Panchsheel Organics Ltd. | Sun Pharmaceutical Industries Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 13.32 | 36.73 | Panchsheel Organics Ltd. |
| Price-to-Book Ratio | 1.16 | 5.15 | Panchsheel Organics Ltd. |
| Debt-to-Equity Ratio | 2.87 | 6.68 | Panchsheel Organics Ltd. |
| PEG Ratio | N/A | 3.59 | N/A |
| EV/EBITDA | 10.98 | 23.61 | Panchsheel Organics Ltd. |
| Profit Margin (TTM) | 11.65% | 19.21% | Sun Pharmaceutical Industries Ltd. |
| Operating Margin (TTM) | 11.91% | 26.17% | Sun Pharmaceutical Industries Ltd. |
| EBITDA Margin (TTM) | 11.91% | 26.17% | Sun Pharmaceutical Industries Ltd. |
| Return on Equity | 10.31% | 15.08% | Sun Pharmaceutical Industries Ltd. |
| Return on Assets (TTM) | 8.45% | 11.87% | Sun Pharmaceutical Industries Ltd. |
| Free Cash Flow (TTM) | $-117.21M | $119.44B | Sun Pharmaceutical Industries Ltd. |
| Dividend Yield | 4.35% | 0.97% | Panchsheel Organics Ltd. |
| 1-Year Return | -21.75% | 7.10% | Sun Pharmaceutical Industries Ltd. |
| Price-to-Sales Ratio (TTM) | 1.55 | 7.05 | Panchsheel Organics Ltd. |
| Enterprise Value | $1.63B | $3,783.37B | Sun Pharmaceutical Industries Ltd. |
| EV/Revenue Ratio | 1.57 | 6.66 | Panchsheel Organics Ltd. |
| Gross Profit Margin (TTM) | 34.38% | 80.96% | Sun Pharmaceutical Industries Ltd. |
| Revenue per Share (TTM) | $78 | $237 | Sun Pharmaceutical Industries Ltd. |
| Earnings per Share (Diluted) | $9.14 | $45.46 | Sun Pharmaceutical Industries Ltd. |
| Beta (Stock Volatility) | -0.30 | 0.11 | Panchsheel Organics Ltd. |
Panchsheel Organics Ltd. vs Sun Pharmaceutical Industries Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Panchsheel Organics Ltd. | 0.25% | -2.14% | -6.92% | 17.23% | -8.63% | -8.39% |
| Sun Pharmaceutical Industries Ltd. | -0.09% | 0.96% | -3.84% | 1.28% | 0.50% | 4.93% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Panchsheel Organics Ltd. | -21.75% | -29.98% | 22.30% | 88.49% | 565.27% | 4,381.13% |
| Sun Pharmaceutical Industries Ltd. | 7.10% | 82.23% | 170.41% | 143.23% | 656.74% | 2,541.29% |
Performance & Financial Health Analysis: Panchsheel Organics Ltd. vs Sun Pharmaceutical Industries Ltd.
| Metric | PANCHSHEEL | SUNPHARMA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.54B | ₹3.88T |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 3,902 | 3,903,142 |
| 90 Day Avg. Volume | 10,174 | 3,253,866 |
| Last Close | ₹119.05 | ₹1,806.00 |
| 52 Week Range | ₹86.10 - ₹184.00 | ₹1,548.00 - ₹1,916.60 |
| % from 52W High | -35.30% | -5.77% |
| All-Time High | ₹425.55 (Sep 05, 2022) | ₹1,960.35 (Sep 30, 2024) |
| % from All-Time High | -72.02% | -7.87% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.02% | 0.14% |
| Quarterly Earnings Growth | 0.00% | 0.16% |
| Financial Health | ||
| Profit Margin (TTM) | 0.12% | 0.19% |
| Operating Margin (TTM) | 0.12% | 0.26% |
| Return on Equity (TTM) | 0.10% | 0.15% |
| Debt to Equity (MRQ) | 2.87 | 6.68 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹105.06 | ₹324.46 |
| Cash per Share (MRQ) | ₹2.86 | ₹115.87 |
| Operating Cash Flow (TTM) | ₹110.43M | ₹110.84B |
| Levered Free Cash Flow (TTM) | ₹137.95M | ₹109.29B |
| Dividends | ||
| Last 12-Month Dividend Yield | 4.35% | 0.97% |
| Last 12-Month Dividend | ₹4.80 | ₹16.50 |
Valuation & Enterprise Metrics Analysis: Panchsheel Organics Ltd. vs Sun Pharmaceutical Industries Ltd.
| Metric | PANCHSHEEL (Apr 24, 2026) | SUNPHARMA (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 13.32 | 36.73 |
| Forward P/E | N/A | 29.48 |
| PEG Ratio | N/A | 3.59 |
| Price to Sales (TTM) | 1.55 | 7.05 |
| Price to Book (MRQ) | 1.16 | 5.15 |
| Market Capitalization | ||
| Market Capitalization | ₹1.54B | ₹3.88T |
| Enterprise Value | ₹1.63B | ₹3.78T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.57 | 6.66 |
| Enterprise to EBITDA | 10.98 | 23.61 |
| Risk & Other Metrics | ||
| Beta | -0.30 | 0.11 |
| Book Value per Share (MRQ) | ₹105.06 | ₹324.46 |
Financial Statements Comparison: Panchsheel Organics Ltd. vs Sun Pharmaceutical Industries Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | PANCHSHEEL (2025) | SUNPHARMA (2025) |
|---|---|---|
| Revenue/Sales | 1.07B | 520.41B |
| Cost of Goods Sold | 693.70M | 121.98B |
| COGS % of Revenue | 64.8% | 23.4% |
| Gross Profit | 377.22M | 398.44B |
| Gross Margin | 35.2% | 76.6% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 154.03M | 125.81B |
| Operating Margin | 14.4% | 24.2% |
| EBITDA | 203.76M | 167.25B |
| EBITDA Margin | 19.0% | 32.1% |
| Pre-Tax Income | 180.97M | 137.52B |
| Pre-Tax Income % of Revenue | 16.9% | 26.4% |
| Income Tax | 43.03M | 27.72B |
| Income Tax % of Revenue | 4.0% | 5.3% |
| Net Income (Profit) | 137.95M | 109.65B |
| Profit Margin | 12.9% | 21.1% |
Balance Sheet & Liquidity Metrics
| Metric | PANCHSHEEL (2025) | SUNPHARMA (2025) |
|---|---|---|
| Cash & Equivalents | 41.52M | 102.69B |
| Total Current Assets | 887.29M | 526.24B |
| Total Current Assets % of Revenue | 82.9% | 101.1% |
| Total Current Liabilities | 242.76M | 181.94B |
| Total Current Liabilities % of Revenue | 22.7% | 35.0% |
| Long-Term Debt | 1.78M | 3.58B |
| Long-Term Debt % of Revenue | 0.2% | 0.7% |
| Total Shareholders Equity | 1.34B | 724.86B |
| Retained Earnings | 637.98M | 578.62B |
| Retained Earnings % of Revenue | 59.6% | 111.2% |
| Property, Plant & Equipment | 12.99M | 100.36B |
Cash Flow Statement Comparison
| Metric | PANCHSHEEL (2025) | SUNPHARMA (2025) |
|---|---|---|
| Operating Cash Flow | 110.43M | 110.84B |
| Operating Cash Flow % of Revenue | 10.3% | 21.3% |
| Capital Expenditures | -155.56M | -20.68B |
| Free Cash Flow | -117.21M | 119.44B |
| FCF Margin | -10.9% | 23.0% |
| Debt Repayment | -8.72M | -43.44B |
| Common Stock Repurchase | N/A | -29.00B |
Short Interest & Institutional Ownership Analysis
| Metric | PANCHSHEEL | SUNPHARMA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 13.17M | 2.40B |
| Float Shares | 5.11M | 1.07B |
| % Held by Insiders | 61.26% | 55.62% |
| % Held by Institutions | 0.00% | 28.69% |
| % Held by Public | 38.74% | 15.69% |
Dividend Analysis & Yield Comparison: Panchsheel Organics Ltd. vs Sun Pharmaceutical Industries Ltd.
| Metric | PANCHSHEEL | SUNPHARMA |
|---|---|---|
| Last 12-Month Dividend | ₹4.80 | ₹16.50 |
| Last 12-Month Dividend Yield | 4.35% | 0.97% |
| 3-Year Avg Annual Dividend | ₹4.00 | ₹17.33 |
| 3-Year Avg Dividend Yield | 0.45% | 0.51% |
| 3-Year Total Dividends | ₹12.00 | ₹52.00 |
| Ex-Dividend Date | Feb 20, 2026 | Feb 05, 2026 |